Israeli online trading platform eToro’s veteran employees and angel investors are selling shares worth $120 million in a secondary deal. In March, eToro raised
Read MoreTag: 120m
UroGen to raise $120m after positive bladder cancer trial
UroGen Pharma (TASE: URGN), which develops uro-oncological treatments, last week published positive results from two clinical trials of bladder cancer treatment UGN-102. This is
Read More